Methylation profiling reveals novel molecular classes of rhabdomyosarcoma

Abstract Rhabdomyosarcomas (RMS) represent a family of aggressive soft tissue sarcomas that present in both children and adults. Pathologic risk stratification for RMS has been based on histologic subtype, with poor outcomes observed in alveolar rhabdomyosarcoma (ARMS) and the adult-type pleomorphic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Michael R. Clay, Anand Patel, Quynh Tran, Dale J. Hedges, Ti-Cheng Chang, Elizabeth Stewart, Greg Charville, Cynthia Cline, Michael A. Dyer, Brent A. Orr
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/2a65920f1718448eb362b6a801462e28
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2a65920f1718448eb362b6a801462e28
record_format dspace
spelling oai:doaj.org-article:2a65920f1718448eb362b6a801462e282021-11-21T12:17:12ZMethylation profiling reveals novel molecular classes of rhabdomyosarcoma10.1038/s41598-021-01649-w2045-2322https://doaj.org/article/2a65920f1718448eb362b6a801462e282021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-01649-whttps://doaj.org/toc/2045-2322Abstract Rhabdomyosarcomas (RMS) represent a family of aggressive soft tissue sarcomas that present in both children and adults. Pathologic risk stratification for RMS has been based on histologic subtype, with poor outcomes observed in alveolar rhabdomyosarcoma (ARMS) and the adult-type pleomorphic rhabdomyosarcoma (PRMS) compared to embryonal rhabdomyosarcoma (ERMS). Genomic sequencing studies have expanded the spectrum of RMS, with several new molecularly defined entities, including fusion-driven spindle cell/sclerosing rhabdomyosarcoma (SC/SRMS) and MYOD1-mutant SC/SRMS. Comprehensive genomic analysis has previously defined the mutational and copy number spectrum for the more common ERMS and ARMS and revealed corresponding methylation signatures. Comparatively, less is known about epigenetic correlates for the rare SC/SRMS or PRMS histologic subtypes. Herein, we present exome and RNA sequencing, copy number analysis, and methylation profiling of the largest cohort of molecularly characterized RMS samples to date. In addition to ARMS and ERMS, we identify two novel methylation subtypes, one having SC/SRMS histology and defined by MYOD1 p. L122R mutations and the other matching adult-type PRMS. Selected tumors from adolescent patients grouped with the PRMS methylation class, expanding the age range of these rare tumors. Limited follow-up data suggest that pediatric tumors with MYOD1-mutations are associated with an aggressive clinical course.Michael R. ClayAnand PatelQuynh TranDale J. HedgesTi-Cheng ChangElizabeth StewartGreg CharvilleCynthia ClineMichael A. DyerBrent A. OrrNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Michael R. Clay
Anand Patel
Quynh Tran
Dale J. Hedges
Ti-Cheng Chang
Elizabeth Stewart
Greg Charville
Cynthia Cline
Michael A. Dyer
Brent A. Orr
Methylation profiling reveals novel molecular classes of rhabdomyosarcoma
description Abstract Rhabdomyosarcomas (RMS) represent a family of aggressive soft tissue sarcomas that present in both children and adults. Pathologic risk stratification for RMS has been based on histologic subtype, with poor outcomes observed in alveolar rhabdomyosarcoma (ARMS) and the adult-type pleomorphic rhabdomyosarcoma (PRMS) compared to embryonal rhabdomyosarcoma (ERMS). Genomic sequencing studies have expanded the spectrum of RMS, with several new molecularly defined entities, including fusion-driven spindle cell/sclerosing rhabdomyosarcoma (SC/SRMS) and MYOD1-mutant SC/SRMS. Comprehensive genomic analysis has previously defined the mutational and copy number spectrum for the more common ERMS and ARMS and revealed corresponding methylation signatures. Comparatively, less is known about epigenetic correlates for the rare SC/SRMS or PRMS histologic subtypes. Herein, we present exome and RNA sequencing, copy number analysis, and methylation profiling of the largest cohort of molecularly characterized RMS samples to date. In addition to ARMS and ERMS, we identify two novel methylation subtypes, one having SC/SRMS histology and defined by MYOD1 p. L122R mutations and the other matching adult-type PRMS. Selected tumors from adolescent patients grouped with the PRMS methylation class, expanding the age range of these rare tumors. Limited follow-up data suggest that pediatric tumors with MYOD1-mutations are associated with an aggressive clinical course.
format article
author Michael R. Clay
Anand Patel
Quynh Tran
Dale J. Hedges
Ti-Cheng Chang
Elizabeth Stewart
Greg Charville
Cynthia Cline
Michael A. Dyer
Brent A. Orr
author_facet Michael R. Clay
Anand Patel
Quynh Tran
Dale J. Hedges
Ti-Cheng Chang
Elizabeth Stewart
Greg Charville
Cynthia Cline
Michael A. Dyer
Brent A. Orr
author_sort Michael R. Clay
title Methylation profiling reveals novel molecular classes of rhabdomyosarcoma
title_short Methylation profiling reveals novel molecular classes of rhabdomyosarcoma
title_full Methylation profiling reveals novel molecular classes of rhabdomyosarcoma
title_fullStr Methylation profiling reveals novel molecular classes of rhabdomyosarcoma
title_full_unstemmed Methylation profiling reveals novel molecular classes of rhabdomyosarcoma
title_sort methylation profiling reveals novel molecular classes of rhabdomyosarcoma
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/2a65920f1718448eb362b6a801462e28
work_keys_str_mv AT michaelrclay methylationprofilingrevealsnovelmolecularclassesofrhabdomyosarcoma
AT anandpatel methylationprofilingrevealsnovelmolecularclassesofrhabdomyosarcoma
AT quynhtran methylationprofilingrevealsnovelmolecularclassesofrhabdomyosarcoma
AT dalejhedges methylationprofilingrevealsnovelmolecularclassesofrhabdomyosarcoma
AT tichengchang methylationprofilingrevealsnovelmolecularclassesofrhabdomyosarcoma
AT elizabethstewart methylationprofilingrevealsnovelmolecularclassesofrhabdomyosarcoma
AT gregcharville methylationprofilingrevealsnovelmolecularclassesofrhabdomyosarcoma
AT cynthiacline methylationprofilingrevealsnovelmolecularclassesofrhabdomyosarcoma
AT michaeladyer methylationprofilingrevealsnovelmolecularclassesofrhabdomyosarcoma
AT brentaorr methylationprofilingrevealsnovelmolecularclassesofrhabdomyosarcoma
_version_ 1718419053690748928